PBYI 8-K: Guidance raise
Puma Biotechnology
Filed with the SEC on · accession 0001437749-26-035279
PBYI filed a 8-K (current report) with the SEC on Nov 5, 2026. Puma Biotechnology reported Q3 2026 financial results with net product revenue of $54.1 million, up from $51.9 million year-over-year, and raised its 2026 net income guidance.
Summary of the filing
Puma Biotechnology reported Q3 2026 financial results with net product revenue of $54.1 million, up from $51.9 million year-over-year, and raised its 2026 net income guidance. The company also highlighted progress in its alisertib clinical development programs.
Key details
✦ Ask GOAX AI about this filing — what it means for PBYI, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for PBYI?
Click hereFrequently asked questions
What did PBYI file with the SEC on Nov 5, 2026?
PBYI filed a 8-K (Guidance raise). Puma Biotechnology reported Q3 2026 financial results with net product revenue of $54.1 million, up from $51.9 million year-over-year, and raised its 2026 net income guidance. The company also highlighted progress in its alisertib clinical development programs.
What does a guidance raise mean for PBYI stock?
Guidance is the company’s own forecast. Investors price stocks on the future, so a raise or cut often moves the stock more than the past quarter’s numbers.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other PBYI SEC filings
Get alerts when PBYI files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days